Podcasts about chernew

CareQuest Institute for Oral Health is a national nonprofit dedicated to creating an oral health care system that is accessible, equitable, and integrated. Learn more about how their advocacy, philanthropy, research, and education are creating a better oral health system at carequest.org/turnonthelights Curious about how we can fix the inefficiencies of the U.S. health care system and ensure better care for all? In this episode, Michael Chernew, the Leonard D. Schaeffer Professor of Health Care Policy at the Department of Health Care Policy at Harvard Medical School, discussed the challenges and reforms in the American health care system. He emphasized the concept of value-based insurance design, which aims to reduce cost-sharing for high-value services to ensure patients receive necessary care. Chernew highlighted the inefficiencies of the fee-for-service system and the importance of payment reforms, particularly within Medicare Advantage, to improve care quality and control costs. He also explained the complexities of the U.S. health care system, influenced by the balance between market forces and government regulation, leading to opaque pricing and administrative burdens. While acknowledging the potential lessons from other countries' health care systems, he noted that adopting foreign models directly may not work due to the unique economic and social landscape of the U.S. Tune in as Professor Michael Chernew unpacks innovative solutions, such as value-based insurance design and payment reforms, that could reshape the future of health care! Learn more about your ad choices. Visit megaphone.fm/adchoices

Join Health Affairs Insider today!Health Affairs' Jeff Byers is joined by Michael Chernew to discuss the recently released National Health Expenditures Projections for 2023–32 from the Office of the Actuary (OACT) at the Centers for Medicare and Medicaid Services (CMS).Join us for these upcoming events:6/18/24 - Journal Club: “Community Power-Building Groups And Public Health NGOs: Reimagining Public Health Advocacy”7/10/24 - Lunch and Learn: Supreme Court Wrap-UpRelated Articles:National Health Expenditure Projections, 2023–32: Payer Trends Diverge As Pandemic-Related Policies Fade (Health Affairs)National Health Expenditure Data from CMS

Understanding healthcare spending growth in America is a critical component of any initiative attempting to improve care quality and affordability. This holds true for every person or organization focused on improving healthcare – from policy makers, to traditional healthcare incumbents, new entrants, and the entrepreneurs driving digital health innovation.There are few people who understand healthcare economics in the U.S. as well as Michael Chernew, PhD, who has dedicated his career to studying healthcare spending and how it affects the quality of care and outcomes. Dr. Chernew is the Leonard D. Schaeffer Professor of Health Care Policy, and director of the Healthcare Markets and Regulation Lab in the Department of Health Care Policy at Harvard Medical School. Among many other roles, he is also currently serving as the Chair of the Medicare Payment Advisory Commission (MedPAC), an independent agency that advises Congress on costs, payments and other issues affecting the Medicare program.Dr. Chernew's research examines several areas related to improving the health care system including studies of novel benefit designs, Medicare Advantage, alternative payment models, low value care and the causes and consequences of rising health care spending.In this episode of Healthcare is Hard, Dr. Chernew shares his knowledge with Keith Figlioli in a discussion that touches a broad range of topics around healthcare economics and innovation, including:The false choice between free markets and government intervention. While some people argue for a stronger government role in healthcare, others believe there needs to be better mechanisms to make markets work better. Dr. Chernew says we need to use the power of the markets where we can and sees a lot of potential for innovation to play a role. But he is also skeptical about how much markets can accomplish on their own. He says the most important thing is to recognize that both the government and the markets are flawed, and he talks about the need to understand where flaws exist in order to navigate them.The appetite for disruptive innovation. There are a lot of organizations now that believe they can deliver good population health for less and capture the gains associated with that efficiency. While the effectiveness of these new approaches generally remains to be seen, Dr. Chernew talks about how there are now many mechanisms in place that will allow organizations to accept risk, along with an appetite for innovation that has grown exponentially over the last decade – especially if it can lower spending.Skepticism on the impact of better primary care. There's a common belief that more and better primary care will ultimately save money because everyone would be healthier. This might be true in some places or situations, but Dr. Chernew says he's very skeptical of the assertion that it could scale in the current system. He explains how saving money is typically achieved by eliminating low value care and providing high value care more efficiently, and talks about potential alternatives for expanding primary care as it exists today.The high cost of drugs. There's a lot of disfunction in the drug market in terms of pricing and value, and the way Dr. Chernew explains it, high costs are really financing future innovation. He says there are core debates about how much innovation should be financed, and how much innovation will occur as a result. He talks about options for designing potential structural changes and incentives to address these issues.To hear Keith and Dr. Chernew talk about these topics and more, listen to this episode of Healthcare is Hard: A Podcast for Insiders.

Health Affairs Editor-in-Chief Alan Weil interviews Michael Chernew from the Harvard Medical School on his recently-published paper examining the effects of lower Medicare Advantage benchmarks on plan, generosity and benefits. The authors found that a $1,000 per year decrease in the benchmarks would lead to only moderate increases in annual premiums, deductibles and co-pays. Order the April 2023 issue of Health Affairs.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.Subscribe: RSS | Apple Podcasts | Spotify | Stitcher | Google Podcasts

Join Health Affairs Insider.Late last month, the Centers for Medicare & Medicaid Services (CMS) announced its redesign of its Global and Professional Direct Contracting Model to its now-branded Accountable Care Organization (ACO) Realizing Equity, Access, and Community Health (REACH) Model. The agency stated the redesign is meant to advance health equity and was in response to stakeholder feedback and participant experience.On today's episode of Health Affairs This Week, Harvard Medical School's Michael Chernew joins Health Affairs Forefront Editor Chris Fleming to talk about the new CMS model for ACOs, and where Medicare Advantage could improve.Related Links: Accountable Care Organization (ACO) Realizing Equity, Access, and Community Health (REACH) Model (CMS) The Case For ACOs: Why Payment Reform Remains Necessary (Health Affairs Forefront) Podcast: Michael Chernew Makes The Case for Payment Reform (Health Affairs This Week) Medicare Advantage, Direct Contracting, And The Medicare 'Money Machine,' Part 2: Building On The ACO Model (Health Affairs Forefront) Subscribe: RSS | Apple Podcasts | Spotify | Castro | Stitcher | Deezer | Overcast

Join Health Affairs Insider.This week on Health Affairs Forefront (formerly known as the Health Affairs Blog), Michael Chernew, director of the Healthcare Markets and Regulation Lab in the Department of Health Care Policy at Harvard Medical School, and Michael McWilliams, professor of medicine at Harvard Medical School, wrote a piece making the case for accountable care organizations (ACOs) and how fee-for-service payment models lack efficiency.Today on Health Affairs This Week, Michael Chernew joins Health Affairs Forefront Editor Chris Fleming to discuss the Forefront piece, ACOs, direct contracting, why health care payment reform remains necessary in 2022, and more.Related Links: The Case For ACOs: Why Payment Reform Remains Necessary (Health Affairs Forefront) Medicare Advantage, Director Contracting, And The Medicare 'Money Machine," Part 1: The Risk-Score Game (Health Affairs Forefront) Coding-Driven Changes In Measured Risk In Accountable Care Organizations (Health Affairs) Podcast: Matthew Trombley on Why Many Providers Run From Downside Risk In ACOs (A Health Podyssey) Subscribe: RSS | Apple Podcasts | Spotify | Castro | Stitcher | Deezer | Overcast

There is a lot of avoidable waste in the basic delivery of care, but this waste is actually an asset for alternative payment models (APMs). Unlike the fee-for-service model that discourages eliminating waste and low-value care because it loses money, APMs can get paid to eliminate that same waste and improve healthcare quality, says health economist @Michael_Chernew, PhD, professor of #healthcare policy at @harvardmed school, and chair of MEDPAC @medicarepayment. In a timely interview with APG President and CEO @DonCrane, Professor Chernew talks about the premise of his recent JAMA article, “A Path Forward for Alternative Payment: Build a Portfolio Not a Garden.” @AmerPhysGrps #Medicare #valuebasedcare  

Listen Now (As explained on the podcast home page, this is the fourth of eight interviews concerning federal healthcare policy...

As 2020 ends, the last interview in a year-long series running during the 25th anniversary of The American Journal of Managed Care® (AJMC®) is with the journal’s co-editors-in-chief: Michael E. Chernew, PhD, and A. Mark Fendrick, MD. This episode of Managed Care Cast is a preview of that conversation, which appears in the December issue. Chernew and Fendrick discuss which issues they think President-elect Joe Biden should prioritize, including the sustainability of Medicare, a continued way forward for the Affordable Care Act, and value-based insurance design, particularly as the continued coronavirus disease 2019 pandemic continues to stress every aspect of health care.

Dr. Michael Chernew is a professor of health care policy and the director of the Healthcare Markets and Regulation Lab at Harvard Medical School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. M.E. Chernew. The Role of Market Forces in U.S. Health Care. N Engl J Med 2020;383:1401-1404.

Suzanne calls Michael Chernew, PhD, director of the Healthcare Markets and Regulation (HMR) Lab in the Department of Health Care Policy at Harvard Medical School. They discuss his December 2019 publication in NEJM Catalyst, “How Different Payment Models Support (or Undermine) a Sustainable Health Care System: Rating the Underlying Incentives and Building a Better Model,” co-authored with Jermaine Heath, AB. The article examines the theory and evidence of fee-for-service, episode-based payments, and population-based payments, and makes recommendations around which payment models can create better incentives. Listen in to get into the weeds on how payment reform works while also staying grounded in a fundamental truth: we can’t expect any Alternative Payment Model (APM) to be successful if the model isn’t sustainable to those who deliver the care.

Listen NowIn CMS' proposed hospital outpatient rule published in the Federal Register in early August, the agency proposed requiring hospitals to make public a list of its negotiated rates for common items and services.   The proposed rule is based on two White House executive orders and is an expansion of a related regulatory rule that went into effect this past January 1st that requires hospitals to make publicly available a list of current standard hospital charges (on their so called chargemaster list).  Despite the administration's enthusiasm for price transparency (and state's - approximately half have passed price transparency legislation) the evidence to date demonstrates that price transparency has not led to or enabled patients to lower their out of pocket costs, lower health care prices, improve market competition creating greater care value.   During this 24 minute conversation Professor Michael Chernew begins by discussing related anti-trust enforcement.  He moreover discusses his research findings concerning price transparency, alternative practices providers have or can exhibit that have demonstrated success in lowering patient out of pocket spending and potential unintended negative consequences, e.g., hospitals may demonstrate less willingness to make price concessions for fear of having to extent them to all payers, should CMS' rule go final as proposed in November. Professor Michael Chernew is the Leonard D. Schaeffer Professor of Health Care Policy and the director of the Healthcare Markets and Regulation (HMR) Lab in the Department of Health Care Policy at Harvard Medical School.  Professor Chernew is a member of the Congressional Budget Office's Panel of Health Advisors and of the Institute of Medicine's Committee on National Statistics (CNSTAT).  He is also a research associate at the National Bureau of Economic Research.  In 2011, he served on the Institute of Medicine's Committee on Determination of Essential Health Benefits and in 2010 was elected to the Institute of Medicine of the National Academy of Sciences.  Prof. Chernew is the former Vice Chair of the Medicare Payment Advisory Commission (MedPAC).  In April 2015, Massachusetts Governor Charlie Baker appointed Professor Chernew to the Massachusetts Health Connector Board of Directors.  Dr. Chernew is currently a co-editor of the American Journal of Managed Care and editor of the Journal of Health Economics.  He is a former senior associate editor of Health Services Research.  Professor Chernew earned his undergraduate degree from the University of Pennsylvania and his PhD in economics from Stanford University.The two White House Executive Orders noted are at: https://www.whitehouse.gov/presidential-actions/executive-order-improving-price-quality-transparency-american-healthcare-put-patients-first/ and at: https://www.whitehouse.gov/presidential-actions/presidential-executive-order-promoting-healthcare-choice-competition-across-united-states/ The White House's related, "Reforming America's Health System" paper is at: https://www.hhs.gov/sites/default/files/Reforming-Americas-Healthcare-System-Through-Choice-and-Competition.pdfCMS' current proposed rule discussing expanding hospital price transparency regulations is at: https://www.govinfo.gov/content/pkg/FR-2019-08-09/pdf/2019-16107.pdf . See pages 39571, ff. The summary of Prof. Chernew, et al. April 2018 New England Journal of Medicine price transparency research article noted during this podcast is at: https://newsatjama.jama.com/2019/08/22/jama-forum-price-transparency-in-health-care-has-been-disappointing-but-it-doesnt-have-to-be/  This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.thehealthcarepolicypodcast.com

This week’s blog is brought to you by Dr Tim Wilson Health Care Spending, Utilization, and Quality 8 Years into Global Payment Song, Z., Ji, Y., Safran, D. G., & Chernew, M. E. (2019). Health Care Spending, Utilization, and Quality 8 Years into Global Payment. New England Journal of Medicine, 381(3), 252–263.

"Public policy and managerial innovation is less about health and more about money (taxes)," says Michael Chernew, Leonard D. Schaeffer Professor of Health Care Policy, Harvard Medical School. So how do we slow spending growth? Payment reform, benefit design, competition/managed care, organization of medical practice, and wellness are all factors that Chernew suspects will play a key role. Jacob Turmell, DNP, RN, NP-C, ACNS-BC, CCRN-CMC, is Vice President of MedAxiom Consulting.For more information, contact: HeartTalk@medaxiom.com or visit https://www.medaxiom.com.

As 2018 draws to a close, The American Journal of Managed Care® (AJMC®)'s co-editors-in-chief, A. Mark Fendrick, MD, director of the Center for Value-Based Insurance Design at the University of Michigan, and Michael E. Chernew, PhD, director of the Healthcare Markets and Regulation Lab at Harvard Medical School, recapped their favorite AJMC® papers published in 2018, identified events from the year that are likely to impact future research in the journal, and looked ahead to 2019 with healthcare and health policy predictions. Read more about the papers and news events mentioned: Financial Burden of Healthcare Utilization in Consumer-Directed Health Plans: https://www.ajmc.com/journals/issue/2018/2018-vol24-n4/financial-burden-of-healthcare-utilization-in-consumer-directed-health-plans A Randomized, Pragmatic, Pharmacist-Led Intervention Reduced Opioids Following Orthopedic Surgery: https://www.ajmc.com/journals/issue/2018/2018-vol24-n11/a-randomized-pragmatic-pharmacistled-intervention-reduced-opioids-following-orthopedic-surgery Overall US Healthcare Spending Growth Slowed for Second Year, CMS Says: https://www.ajmc.com/focus-of-the-week/overall-us-healthcare-spending-growth-slows-for-second-year-cms-says Levers to Reduce Use of Unnecessary Services: Creating Needed Headroom to Enhance Spending on Evidence-Based Care: https://www.ajmc.com/journals/issue/2018/2018-vol24-n8/levers-to-reduce-use-of-unnecessary-services-creating-needed-headroom-to-enhance-spending-on-evidencebased-care Addressing Low-Value Care and a Better Benefit Design at the V-BID Summit: https://www.ajmc.com/managed-care-cast/addressing-lowvalue-care-and-a-better-benefit-design-at-the-vbid-summit Federal Judge Strikes Down Affordable Care Act: https://www.ajmc.com/newsroom/federal-judge-strikes-down-affordable-care-act In the Wake of ACA Ruling, the Only Thing Certain Is Uncertainty: https://www.ajmc.com/focus-of-the-week/in-the-wake-of-aca-ruling-the-only-thing-certain-is-uncertainty

Creators of President Donald Trump’s blueprint to control drug prices, American Patients First, say it represents real reform. Critics see a pulled punch to the pharmaceutical industry. Mary Caffrey, the managing editor of The American Journal of Managed Care’s Evidence-Based series, spoke with Harvard healthcare economist Michael E. Chernew, PhD, who is the co-editor in chief of AJMC, to discuss elements of the Trump administration proposal to control drug prices. Chernew is also a former vice chair of the Medicare Payment Advisory Commission. Read more: Trump Offers Blueprint to Drive Down Prescription Drug Prices; Targets Rebates, "Middlemen": www.ajmc.com/newsroom/-trump-offers-blueprint-to-drive-down-prescription-drug-prices-targets-rebates-middlemen Azar Stumps for Plan to Hold Down Prescription Drug Costs: www.ajmc.com/focus-of-the-week/azar-stumps-for-plan-to-hold-down-prescription-drug-costs Trump Targets Drug Prices, Right-to-Try in State of the Union: www.ajmc.com/newsroom/trump-targets-drug-prices-righttotry-in-state-of-the-union ​​​​​​​Will Trump Take Steps to Rein in Drug Prices?: www.ajmc.com/focus-of-the-week/will-trump-take-steps-to-rein-in-drug-prices

Suzanne is curious to learn from Michael Chernew, Health Economist and Professor at the Harvard Medical School, about employers' role in demanding and participating in evaluations of payment and delivery reform programs and what they need to know when launching a new program to ensure it can be subject to rigorous evaluation.

Katy Spangler, the American Benefits Council’s senior vice president, health policy, talks to Harvard Medical School Professor Michael Chernew, PhD, about health care costs, the promise of value-based insurance and what it all has to do with peanut butter and jelly.

Michael Chernew is a professor of health care policy in the Department of Health Care Policy at Harvard Medical School. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. A. Alhassani, A. Chandra, and M.E. Chernew. The Sources of the SGR "Hole". N Engl J Med 2012;366:289-91.